Arndt Vogel (@ArndtVogel) / X

Arndt Vogel

2,414 posts

Arndt Vogel

@ArndtVogel

Clinician-Scientist, ESMO Ambassador, focussed on Liver Cancer & Precision Oncology, Toronto General Hospital/Princess Margaret Cancer Center 🇨🇦/MHH🇩🇪

Hannover

Joined February 2013

Arndt Vogel
@ArndtVogel
May 3, 2023
🔥Lynch syndrome: a single hereditary cancer syndrome or multiple syndromes defined by different mismatch repair genes? @AGA_Gastro doi.org/10.1053/j.gast… 🧐Interesting food for thoughts on tumor risk and carcinogenesis in #Coloncancer @myESMO @OncoAlert
41K
Arndt Vogel
@ArndtVogel
Sep 6, 2023
🔥hot off the press: Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment & follow-up @Annals_Oncology doi.org/10.1016/j.anno… 👉we provide comprehensive recommendations for #PDAC 👏excellent team effort! 🙏thanks to T. Conroy & @DucreuxMichel @myESMO
29K
Arndt Vogel
@ArndtVogel
Sep 8, 2023
🔥I am delighted to announce that I have started a new position at the Toronto General Hospital/Princess Margaret Cancer supported by the the Longo Family Chair in Liver Cancer Research 😀I am very excited and look forward to fruitful & successful collaborations with friends &
University of Toronto Gastroenterology+Hepatology
@UofTGastroHep
Sep 8, 2023
The Division of Gastroenterology and Hepatology at @UofT_DoM and @UHN is proud to welcome Dr. Arndt Vogel (@ArndtVogel) to our faculty as a Clinician Scientist, where he will hold the Longo Family Chair in Liver Cancer Research. Announcement below vvvvvvvvvvvvvvvvvvv
55K
Arndt Vogel
@ArndtVogel
Jun 2, 2024
🔥PLENARY Session #ASCO24🔥 Perioperative chemotherapy (FLOT) to neoadjuvant chemoradiation (CROSS) in patients with adenocarcinoma of the esophagus 🔎 ESOPEC phase III trial, 438 patients 👉R0 180 vs 171 👉pCR 17 vs 10% 👉mOS 66 vs 37 mo 👉3yr OS: 57.4 vs 50.7% 🧐FLOT improves
52K
Arndt Vogel
@ArndtVogel
Dec 17, 2024
🔥Hot off the press: ESMO Clinical Practice Guideline interim update on the management of biliary tract cancer @ESMO_Open doi.org/10.1016/j.esmo… 👉get the lastest update on the management of biliary tract cancer @myESMO @EASLedu @ILCAnews @curecc #livertwitter
32K
Arndt Vogel
@ArndtVogel
Jun 22, 2024
Colorectal cancer @TheLancet doi.org/10.1016/S0140-… 👏comprehensive review 👉locoregional options: SBRT to LTx 👉more systemic therapy 👉improved treatment selection 👉precision oncology, AI, microbiome.. everything covered 😅 @myESMO
32K
Arndt Vogel
@ArndtVogel
Apr 16, 2023
🔥Hot of the press: Pembrolizumab in combination with GemCis compared with GemCis in biliary tract cancer @TheLancet 👇doi.org/10.1016/S0140-… 🔎KEYNOTE-966🗺️phs-III 1069 pts 💪Significant OS ⬆️ ✅ICI = integral part of systemic 💊 in BTC @myESMO @CcaEns @EASLedu #livertwitter
101K
Arndt Vogel
@ArndtVogel
Sep 7, 2022
🔥🔥The Lancet has just published our Seminar „Hepatocellular carcinoma“🔥🔥 @TheLancet 🙏Special thanks to this awesome team @SaborowskiAnna @RiadSalemIR @sapisochin & Tim Meyer 👇Link to free full text: authors.elsevier.com/a/1fimSV-4XHF1a @myESMO @EASLedu @OncoAlert #livertwitter #HCC
Arndt Vogel
@ArndtVogel
Dec 17, 2024
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma @JHepatology doi.org/10.1016/j.jhep… 🔥Get the new guideline for HCC 👉Up to date, very granular recommendations @EASLedu @myESMO @ILCAnews #livertwitter
27K
Arndt Vogel
@ArndtVogel
Feb 20, 2025
🔥off the press: Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up @Annals_Oncology doi.org/10.1016/j.anno… 👉get the lastest update on HCC management 👉Multiple options > MDT is key @myESMO @EASLedu @ILCAnews #livertwitter
31K
Arndt Vogel
@ArndtVogel
Jun 2, 2024
Surgery vs ablation for small-size CRC liver mtes at #ASCO24 🔎COLLISION phase III, 300 pts 👉medien size 14mm, 2mets 👉mOS: no difference 👉similar local control 👉reduced morbidity & mortality in ablation arm 🧐Ablation very valid option @myESMO @ILCAnews @EASLnews
50K
Arndt Vogel
@ArndtVogel
Dec 26, 2022
🔥Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021 @BioMedCentral doi.org/10.1186/s13045… 👉Comprehensive summary of 120 approvals on oncology @OncoAlert @myESMO
30K
Arndt Vogel
@ArndtVogel
Jul 27, 2023
🔥Just out: The ESMO #GastricCancer Living Guideline 👉get the latest news & updates for daily decision making @myESMO @OncoAlert
27K
Arndt Vogel
@ArndtVogel
Feb 4, 2023
😇Now fully published: 🇪🇺Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆ @Annals_Oncology 👇doi.org/10.1016/j.anno… @myESMO @EASLedu #livertwitter @CcaEns
17K